Clinical Trial Update: Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy for the Treatment of Sexual Function Impairment in Women Aged 40-50 [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial completed evaluating autologous adipose-derived mesenchymal stem cell therapy for female sexual dysfunction in women aged 40-50, focu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Sexual Dysfunction

Drugs mentioned

• Autologous adipose-derived mesenchymal stem cell therapy

Snippet

Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology | Conditions: Female Sexual Dysfunction | Phase 1, Phase 2 | Status: COMPLETED